Evidence map›Paper›PMID 32937636›Full record

ArticleJournal of innate immunity2021

In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation.

Yoojin Lee, Heewook Shin, Jongsun Kim

Open access · goldAbstract read
In one paragraph

Article in Journal of innate immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Physical Exercise in Immunotherapy.Sports medicine - open · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Eating for immunity: how diet shapes our defenses.Current opinion in immunology · 2024
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. What nature has to offer: Opportunities for immuno-oncology.Journal of food and drug analysis · 2023
    Review
  19. Article
  20. Advances in NK cell therapy for brain tumors.NPJ precision oncology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yoojin LeeDepartment of Microbiology and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
Heewook ShinDepartment of Microbiology and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jongsun KimDepartment of Microbiology and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea, jkim63@yuhs.ac.
Yonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer (NK) cells are innate immune lymphocytes that play an important role in anti-viral and anti-tumour immune responses. Several cancer immunotherapy approaches targeting NK cells are currently in clinical or preclinical development. Here, we aimed to find food nutrients that activate NK cells and determine their usefulness as candidates for anti-cancer and anti-metastatic drugs. Resveratrol appeared to activate NK cells most effectively among the substances tested and synergistically increased IFN-γ secretion and NK cell cytotoxicity with interleukin-2 (IL-2). CD107a, NKp30, and NKG2D expression levels were upregulated on the surface of NK cells upon treatment with resveratrol in combination with IL-2 compared with treatment with IL-2 alone. Moreover, NK cell activity in human and mouse whole blood was enhanced upon treatment with resveratrol. Most importantly, administration of resveratrol effectively inhibited tumour growth and metastasis in mice. In conclusion, we suggest that resveratrol may represent a candidate anti-cancer drug that acts by activating NK cells in vivo.

Indexed as

AnimalsAntineoplastic AgentsCytotoxicity, ImmunologicFemaleHumansImmunity, InnateInterferon-gammaInterleukin-2Killer Cells, NaturalLymphocyte ActivationLysosomal-Associated Membrane Protein 1Melanoma, ExperimentalMiceNatural Cytotoxicity Triggering Receptor 3Neoplasm MetastasisNeoplasms, ExperimentalAntineoplastic AgentsInterferon-gammaInterleukin-2KLRK1 protein, humanLysosomal-Associated Membrane Protein 1Natural Cytotoxicity Triggering Receptor 3NCR3 protein, humanNK Cell Lectin-Like Receptor Subfamily KNutrientsResveratrolImmunotherapyInterferon-gammaNatural killer cellNatural killer cytotoxicityResveratrol

Identifiers

PMID32937636
PMCPMC8077674
OpenAlexW3087384795

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.